P. Rougier and E. Mitry, Colorectal cancer chemotherapy: irinotecan, Semin. Oncol, vol.27, pp.138-181, 2000.

J. Wang, Cellular roles of DNA topoisomerases: a molecular perspective, Nature Reviews Molecular Cell Biology, vol.351, issue.6, pp.430-470, 2002.
DOI : 10.1038/nrm831

J. Leppard and J. Champoux, Human DNA topoisomerase I: relaxation, roles, and damage control, Chromosoma, vol.32, issue.2, pp.75-85, 2005.
DOI : 10.1007/s00412-005-0345-5

Y. Pommier, P. Pourquier, Y. Fan, and D. Strumberg, Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1400, issue.1-3, pp.83-105, 1998.
DOI : 10.1016/S0167-4781(98)00129-8

T. Furuta, H. Takemura, Z. Liao, G. Aune, C. Redon et al., Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes, Journal of Biological Chemistry, vol.278, issue.22, pp.20303-20315, 2003.
DOI : 10.1074/jbc.M300198200

S. Kawabata, M. Oka, K. Shiozawa, K. Tsukamoto, K. Nakatomi et al., Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells, Biochemical and Biophysical Research Communications, vol.280, issue.5, pp.1216-1239, 2001.
DOI : 10.1006/bbrc.2001.4267

L. Candeil, I. Gourdier, D. Peyron, N. Vezzio, V. Copois et al., ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases, International Journal of Cancer, vol.63, issue.6, pp.848-54, 2004.
DOI : 10.1002/ijc.20032

Y. Sugimoto, S. Tsukahara, T. Oh-hara, T. Isoe, and T. Tsuruo, Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody, Cancer Res, vol.50, pp.6925-6955, 1990.

R. Woessner, W. Eng, G. Hofmann, D. Rieman, F. Mccabe et al., Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content, Oncol. Res, vol.4, pp.481-489, 1992.

L. Wang, C. Ting, C. Lo, J. Su, L. Mickley et al., Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance, Cancer Res, vol.57, pp.1516-1538, 1997.

Y. Pommier, C. Redon, V. Rao, J. Seiler, O. Sordet et al., Repair of and checkpoint response to topoisomerase I-mediated DNA damage, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.532, issue.1-2, pp.173-203, 2003.
DOI : 10.1016/j.mrfmmm.2003.08.016

J. Chrencik, B. Staker, A. Burgin, P. Pourquier, Y. Pommier et al., Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations, Journal of Molecular Biology, vol.339, issue.4, pp.773-84, 2004.
DOI : 10.1016/j.jmb.2004.03.077

Y. Arakawa, H. Suzuki, S. Saito, and H. Yamada, Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells, Molecular Cancer Therapeutics, vol.5, issue.3, pp.502-510, 2006.
DOI : 10.1158/1535-7163.MCT-05-0246

M. Van-der-merwe and M. Bjornsti, Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin, Journal of Biological Chemistry, vol.283, issue.6, pp.3305-3320, 2008.
DOI : 10.1074/jbc.M705781200

C. Losasso, E. Cretaio, P. Fiorani, D. Annessa, I. Chillemi et al., A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance, Nucleic Acids Research, vol.36, issue.17, pp.5635-5679, 2008.
DOI : 10.1093/nar/gkn557

Y. Pommier, P. Pourquier, Y. Urasaki, J. Wu, and G. Laco, Topoisomerase I inhibitors: selectivity and cellular resistance, Drug Resistance Updates, vol.2, issue.5, pp.307-325, 1999.
DOI : 10.1054/drup.1999.0102

P. Fiorani, A. Bruselles, M. Falconi, G. Chillemi, A. Desideri et al., Single Mutation in the Linker Domain Confers Protein Flexibility and Camptothecin Resistance to Human Topoisomerase I, Journal of Biological Chemistry, vol.278, issue.44, pp.43268-75, 2003.
DOI : 10.1074/jbc.M303899200

N. Ohashi, Y. Fujiwara, N. Yamaoka, O. Katoh, Y. Satow et al., No Alteration in DNA Topoisomerase I Gene Related to CPT-11 Resistance in Human Lung Cancer, Japanese Journal of Cancer Research, vol.14, issue.1470, pp.1280-1287, 1996.
DOI : 10.1111/j.1349-7006.1996.tb03144.x

H. Takatani, M. Oka, M. Fukuda, F. Narasaki, R. Nakano et al., Gene Mutation Analysis and Quantitation of DNA Topoisomerase I in Previously Untreated Non-small Cell Lung Carcinomas, Japanese Journal of Cancer Research, vol.54, issue.2, pp.160-165, 1997.
DOI : 10.1111/j.1349-7006.1997.tb00361.x

J. Tsurutani, T. Nitta, T. Hirashima, T. Komiya, H. Uejima et al., Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan, Lung Cancer, vol.35, issue.3, pp.299-304, 2002.
DOI : 10.1016/S0169-5002(01)00425-1

C. Gongora, L. Candeil, N. Vezzio, V. Copois, V. Denis et al., Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38, Cancer Biology & Therapy, vol.7, issue.6, pp.822-854, 2008.
DOI : 10.4161/cbt.7.6.5838

J. Soret, M. Gabut, C. Dupon, G. Kohlhagen, J. Stévenin et al., Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I, Cancer Res, vol.63, pp.8203-8214, 2003.

D. Subramanian, E. Kraut, A. Staubus, D. Young, and M. Muller, Analysis of topoisomerase I/DNA complexes in patients administered topotecan, Cancer Res, vol.55, pp.2097-103, 1995.

. Gongora, Molecular Cancer http://www.molecular-cancer.com/content, p.6464, 2011.

X. Michalet, R. Ekong, F. Fougerousse, S. Rousseaux, C. Schurra et al., Dynamic Molecular Combing: Stretching the Whole Human Genome for High-Resolution Studies, Science, vol.277, issue.5331, pp.1518-1541, 1997.
DOI : 10.1126/science.277.5331.1518

G. Versini, I. Comet, M. Wu, L. Hoopes, E. Schwob et al., The yeast Sgs1 helicase is differentially required for genomic and ribosomal DNA replication, The EMBO Journal, vol.22, issue.8, pp.1939-1988, 2003.
DOI : 10.1093/emboj/cdg180

P. Pasero, A. Bensimon, and E. Schwob, Single-molecule analysis reveals clustering and epigenetic regulation of replication origins at the yeast rDNA locus, Genes & Development, vol.16, issue.19, pp.2479-84, 2002.
DOI : 10.1101/gad.232902

D. Rio, M. Molina, F. Bascoul-mollevi, C. Copois, V. Bibeau et al., Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan, J Clin Oncol, vol.25, pp.773-80, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00147002

J. Seiler, C. Conti, A. Syed, M. Aladjem, and Y. Pommier, The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses, Molecular and Cellular Biology, vol.27, issue.16, pp.5806-5824, 2007.
DOI : 10.1128/MCB.02278-06

S. Tuduri, L. Crabbé, C. Conti, H. Tourrière, H. Holtgreve-grez et al., Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription, Nature Cell Biology, vol.20, issue.11, pp.1315-1339, 2009.
DOI : 10.1038/ncb1984

URL : https://hal.archives-ouvertes.fr/hal-00533325

M. Erali, K. Voelkerding, and C. Wittwer, High resolution melting applications for clinical laboratory medicine, Experimental and Molecular Pathology, vol.85, issue.1, pp.50-58, 2008.
DOI : 10.1016/j.yexmp.2008.03.012

M. Redinbo, L. Stewart, J. Champoux, and W. Hol, Structural Flexibility in Human Topoisomerase I Revealed in Multiple Non-isomorphous Crystal Structures, Journal of Molecular Biology, vol.292, issue.3, pp.685-696, 1999.
DOI : 10.1006/jmbi.1999.3065

L. Stewart, G. Ireton, and J. Champoux, A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay, Journal of Biological Chemistry, vol.274, issue.46, pp.32950-60, 1999.
DOI : 10.1074/jbc.274.46.32950

C. Losasso, E. Cretaio, K. Palle, L. Pattarello, M. Bjornsti et al., Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality, Journal of Biological Chemistry, vol.282, issue.13, pp.9855-64, 2007.
DOI : 10.1074/jbc.M608200200

K. Palle, D. Montaudon, D. Rio, M. Tautu, M. Martineau et al., Residue Arg621 stabilizes a hydrogen bond network in DNA topoisomerase I necessary for colon cancer cell sensitivity to irinotecan, Proc Am Assoc Cancer Res Denver, CO. Philadelphia, 2009.

B. Staker, K. Hjerrild, M. Feese, C. Behnke, A. Burgin et al., The mechanism of topoisomerase I poisoning by a camptothecin analog, Proc. Natl. Acad. Sci, pp.15387-15392, 2002.

J. Chrencik, B. Staker, A. Burgin, P. Pourquier, Y. Pommier et al., Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations, Journal of Molecular Biology, vol.339, issue.4, pp.773-784, 2004.
DOI : 10.1016/j.jmb.2004.03.077